Food & Drug Administration Semaglutide injection, National Library of Medicine (2024) FDA approves new drug treatment for chronic weight management, first since 2014, U.S
Venous Stasis: Increased blood viscosity from dehydration slows blood flow, especially in the leg veins, increasing the risk of deep vein thrombosis (DVT) due to venous stasis
Ongoing clinical trials aim to confirm its efficacy and long-term metabolic benefits, positioning mazdutide as a promising next-generation therapy for obesity and related metabolic disorders
Its higher-dose version, Wegovy , is approved specifically for weight management
[2] Willoughby, D., Hewlings, S., & Kalman, D
Additionally, research shows that obstructive sleep apnea can increase a persons risk of: Low oxygen levels while sleeping causes many diseases and sudden life threatening events, Seth Kipnis, MD, medical director of bariatric and robotic surgery at the Hackensack Meridian Jersey Shore University Medical Center in New Jersey, explained